OTX-DP

· Ocular Therapeutix, Inc.

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for OTX-DP, covering 2016-03-30 to 2021-10-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic Conjunctivitis [Phase 3]